Position
Squarepoint Ops LLC in Kyverna Therapeutics, Inc.
Back to the book · All holders of KYTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$106.9K$9.40 → $8.63
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 138.9K | $1.31M | — | — | — | 0.0% |
| Q1 2026 | 147K | $1.27M | $8.63 | −$106.9K | $70K | 0.0% |